34
Participants
Start Date
January 31, 2007
Primary Completion Date
January 31, 2008
Study Completion Date
January 31, 2008
Vinflunine
solution for injection, IV, vinflunine: 280/320 mg/m2 + gemcitabine: 1000 mg/m2, every 3 wks, variable duration
Gemcitabine
solution for injection, IV, placebo + gemcitabine, 1000 mg/m2, every 3 wks, variable duration
Placebo
Local Institution, Manila
Local Institution, Quezon City
Local Institution, Antwerp
Local Institution, København Ø
Local Institution, Tweed Heads
Local Institution, Edegem
Local Institution, Herlev
Local Institution, Adelaide
Local Institution, Odense C
Local Institution, Cebu
Local Institution, Aarhus
Local Institution, Davao City
Columbia University Medical Center, New York
New York Presbyterian Hospital, New York
Local Institution, Bangkok
Albert Einstein Cancer Center, The Bronx
Local Institution, Jakarta
Local Institution, Athens
The Mary Imogene Bassett Hospital, Cooperstown
Local Institution, Caen
University Of Rochester, Rochester
Guthrie Foundation For Education And Research, Sayre
Abramson Cancer Center Of The, Philadelphia
Local Institution, Newark
Local Institution, Milan
Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore
Virginia Oncology Associates, Norfolk
Cancer Outreach Associates, Pc, Abingdon
West Virginia University, Morgantown
Carolinas Hematology Oncology Associates, Charlotte
Charleston Cancer Center, Charleston
Medical University Of South Carolina, Charleston
Local Institution, Murcia
Medical College Of Georgia, Augusta
Central Georgia Cancer Care, Pc, Macon
University Of Florida College Of Medicine At Jacksonville, Jacksonville
Local Institution, Jacksonville
University Of Miami, Miami
Advanced Medical Specialties, Miami
Lakeland Regional Cancer Center, Lakeland
University Of Alabama At Birmingham, Birmingham
The Sarah Cannon Research Institute, Nashville
Local Institution, Trento
The West Clinic, Memphis
The Jones Clinic, Pc, Germantown
Local Institution, Santander
James Graham Brown Cancer Center, Louisville
Mid-Ohio Oncology/Hematology, Inc. Dba, Columbus
Cleveland Clinic, Cleveland
Michiana Hematology Oncology, P.C., South Bend
Mitchell Folbe, Md, Pc, Troy
Henry Ford Hospital, Detroit
Local Institution, Milwaukee
Local Institution, Vandœuvre-lès-Nancy
Local Institution, Minneapolis
Local Institution, Rochester
Mid Dakota Clinic, Pc, Bismarck
Billings Clinic, Billings
Hematology Oncology Centers Of The Northern Rockies, Pc, Billings
University Of Chicago, Chicago
Springfield Clinic, Llp, Springfield
Washington University School Of Medicine, St Louis
Kansas City Veterans Affairs Medical Center, Kansas City
Capital Comprehensive Cancer Care Center, Jefferson City
Missouri Cancer Associates, Columbia
University Of Missouri Healthcare/Ellis Fischel Cancer Ctr, Columbia
Local Institution, Paris
The Center For Cancer And Blood Disorders, Fort Worth
University Of Texas Medical Branch Of Galveston, Galveston
South Texas Oncology And Hematology, P.A., San Antonio
Cancer Specialists Of South Texas, Pa, Corpus Christi
Lone Star Oncology Consulants, Pa, Austin
Northern Utah Associates, Ogden
Acrc/Arizona Clinical Research Center, Inc., Tucson
Nevada Cancer Institute, Las Vegas
Nevada Cancer Centers, Las Vegas
Tower Hematology Oncology Medical Group, Beverly Hills
Glendale Memorial Hospital And Health Center, Glendale
North Valley Hematology/Oncology Medical Group, Mission Hills
Moores Ucsd Cancer Center, La Jolla
Local Institution, Orange
Stanford University, Stanford
Local Institution, Concord
Virginia Mason Medical Center, Seattle
Univ. Of Washington Medical Ctr., Prostate-Oncology Ctr, Seattle
Local Institution, Moscow
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Obninsk
The Cancer Center At Hackensack University Medical Center, Hackensack
Local Institution, Moncton
Local Institution, Sydney
Local Institution, London
Local Institution, Montreal
Local Institution, Viterbo
Local Institution, Bialystok
Local Institution, Gdansk
Local Institution, Krakow
Local Institution, Olsztyn
Local Institution, Poznan
Local Institution, Warsaw
Local Institution, Seongnam-si
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Barcelona
Local Institution, Barcelona
Local Institution, Palma de Mallorca
Local Institution, Sabadell (Barcelona)
Local Institution, Cardiff
Local Institution, Grimsby
Local Institution, Nottingham
Local Institution, Birmingham
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY